BRISA AdvisorsBIHSgropoAlliance Club
MEDICA 2026 · Düsseldorf, 16–19 November

More value.
Same players.
Better model.

Manufacturers, distributors and hospitals — finally connected through one intelligent infrastructure, instead of a fragmented chain that adds cost at every step.

Talk to us on WhatsApp 📅 Book a call
No booth this year — we're walking the floor and taking meetings. Message us to set up a time.
US$16.15B
Brazil healthcare device market, 2025
2,800+
Hospitals we connect you to
30+ yrs
ANVISA expertise
100%
ANVISA approval rate, 2025
The problem you already know

Brazil is blocking your best product.

Your device could be saving lives in Brazilian hospitals. Instead, it's waiting — stuck in regulatory limbo, lost in an unreliable distribution chain, or priced out by tax stacking. Not anymore.

01

ANVISA registration timelines are unpredictable

Two registration pathways, complex dossier requirements, and a mandatory Brazilian legal representative — with timelines that are hard to plan around without local expertise.

02

Import taxes erode your competitiveness

Import duty, IPI, ICMS, PIS and COFINS stack on top of each other — and every distribution layer adds its own margin on top of that.

03

Finding the right distributor is unpredictable — and costly

Thousands of companies sell medical devices in Brazil, most of them very small. Finding one that's compliant and commercially capable is why most manufacturers give up before they start.

The path — four pillars

One infrastructure. Your product in Brazilian hospitals.

01 · Regulatory

ANVISA registration

Full regulatory structure in Brazil, held by BIHS — your independent Brazilian Registration Holder (BRH), never controlled by a single distributor.

02 · Market access

Hospital demand platform

Direct access to hospital demand through one integrated platform — gropo, connecting you to a base of 2,800+ buying hospitals.

03 · Distribution

National network

A pre-qualified distribution network, ready to execute across Brazil — Alliance Club, covering all 27 state capitals.

04 · Cost strategy

Optimized market entry

A more competitive landed cost through one qualified channel — without the stacked margins of a fragmented chain.

How it works

From first conversation to hospital buyers — four steps.

01

Strategic call

A free 30-minute session mapping your regulatory path, tax structure and distribution model.

02

ANVISA roadmap

A complete registration plan with timeline, cost, and Brazilian Registration Holder structure.

03

Distribution build-out

Alliance Club activates your national network by specialty and region.

04

Hospital reach

gropo puts your products in front of the hospital buyers in its base.

30+
Years, since 1995
3,000+
Products registered with ANVISA in 30+ years
600+
Manufacturers served
27
State capitals in the distribution model

Brazil's medical device market: US$16.15B in 2025, projected to reach US$25B by 2032 (Fortune Business Insights) — the largest medical device market in Latin America, with ~7,309 hospitals nationwide. Suppliers wait ~139 days on average to be paid (ABRAIDI, 2025) — our model is built to improve that position.

Let's talk in Düsseldorf.

No booth this year — we're walking the floor and taking meetings. Message us and we'll find a time that works.

Prefer email?

Leave your details — we'll follow up.

Talk to BRISA Advisors

We'll get back to you within 24 hours.
Your data is confidential. We'll respond within 24 hours.